Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway

NCT04209491 | Unknown

• 1 other identifier: APHP 180129
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

This project is based on the assumption that the nurse coordinators of the centres have common missions at each of the key stages of patient care. These missions make the care plan more fluid and improve the quality and safety of care as well as the patient's prognosis. The Hypothesis is that co-follow-up by a doctor and a nurse coordinator reduces time between referral to treatment, average lengths of stay, unscheduled readmissions or early emergency visits, compared to follow-up that does not involve a nurse coordinator.

Conditions

Hepatocellular Carcinoma

Outcome Measures

Primary Outcomes (1)

• Proportion of the following missions of the coordinator Nurse

  missions: o Initial contact of the patient with the expert centre * Organisation of the MDT meeting * Organisation of treatment and investigations * Coordination between hospital professionals * Link with community health professionals * Follow-up (post-hospitalization, treatment side effects, etc.) * Information, advice to patients * Psychological support * Implementation of care pathways * Nursing research

  12 months

Secondary Outcomes (8)

• Timeframe in days between The first contact with the centre and the first interventional radiology treatment.

  12 months

• Timeframe in days between : The first contact with the centre and the first presentation at a MDT meeting

  12 months

• Timeframe in days between : The first contact with the centre and the diagnostic consultation

  12 months

• Timeframe in days between :The first contact with the centre and discharge from the hospital

  12 months

• Timeframe in days between :The interventional radiology procedure and the next one for the subgroup of patients who have multiple procedures during the follow-up period

  12 months

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient with a diagnosis of localized hepatocellular carcinoma.

You may qualify if:

• Centre with interventional radiology treatment
• Active list of patients followed for a HCC of at least 70 / year
• Reply to the feasibility questionnaire within 60 days from receipt of the email

You may not qualify if:

• Patient with a localized HCC diagnosis (BCLC A or B)
• Hospitalised for a first interventional radiology treatment (radioembolisation, transarterial chemoembolization or percutaneous ablation) in one of the centres included in the study between July 1, 2017 and December 31, 2017

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead

Study Sites (1)

BEAUJON Hospital

Clichy-sous-Bois, 92110, France

RECRUITING

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Neoplasms; Liver Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Digestive System Diseases; Liver Diseases

Study Officials

• Julie DEVICTOR

  Assistance Publique - Hôpitaux de Paris

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie JD DEVICTOR

CONTACT

0664712675; julie.devictor@aphp.fr

Mohamed MB BOUATTOUR, Dr

CONTACT

mohamed.bouattour@aphp.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 20, 2019
• First Posted: December 24, 2019
• Study Start: September 9, 2019
• Primary Completion: February 1, 2020
• Study Completion: February 1, 2020
• Last Updated: January 9, 2020

Record last verified: 2019-12

Locations

FR (1)